臨床試驗

ELUCIDATE FFRct Study

NCT：NCT06018194 · COMPLETED

NCT IDNCT06018194

狀態COMPLETED

開始日期2023-09-01

完成時間2025-07-28

SponsorElucid Bioimaging Inc. (INDUSTRY)

First posted2023-08-30

Last updated2026-09-10

簡要摘要

The goal of this study is to evaluate the diagnostic accuracy of a novel plaque-based coronary CT angiography (CCTA) fractional flow reserve (FFRct) software device for the estimation of invasive fractional flow reserve (FFR). Researchers will compare the Elucid plaque-based FFRct analysis to invasively measured FFR in patients who have previously undergone CCTA and invasively assessed FFR.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。